Quest Diagnostics Inc (DGX)

Services-Medical Laboratories

Latest Price

$233.07

TTM P/E

24.74

Normalized P/E

27.61

Div Yield

1.42%

Book Value

67.90

P/B Ratio

3.43

Valuation metrics

EPS: $8.75

Book value / share: $63.45

Formula: √(22.5 × EPS × BVPS)

Graham Number

$111.77

52% downside

Norm. op. income: $1.4B (median of 7yr)

Tax rate: 23%

Discount rate: 10%

Growth assumption: zero (EPV is a no-growth value)

Earnings Power Value

$50.87

78% downside

Base FCF: $1.3B (median of recent 5yr)

Growth: 10%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$246.53

+6% upside

EPS: $8.75

Target P/E: 28×

Formula: EPS × P/E

P/E Fair Value

$245.00

+5% upside

93.9% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
BlackRock, Inc.	9.28M	$1.97B	8.43%	+103.1K	2026-06-30
Vanguard Capital Management LLC	7.23M	$1.53B	6.58%	+87.7K	2026-06-30
Vanguard Portfolio Management LLC	6.13M	$1.30B	5.57%	+49.6K	2026-06-30
State Street Corp	5.52M	$1.17B	5.02%	+135.8K	2026-06-30
Price T Rowe Associates Inc	5.44M	$1.15B	4.95%	-853.0K	2026-06-30
Boston Partners	4.74M	$1.00B	4.31%	+732.2K	2026-06-30
JPMorgan Chase & Co	3.52M	$748.0M	3.20%	-625.5K	2026-06-30
Geode Capital Management, LLC	3.14M	$662.0M	2.85%	+51.6K	2026-06-30
Morgan Stanley	2.46M	$521.0M	2.24%	-19.2K	2026-06-30
EdgePoint Investment Group Inc.	2.25M	$476.0M	2.04%	+3.7K	2026-06-30